![Stephen J. Petti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen J. Petti
Founder at Hibernaid, Inc.
Stephen J. Petti active positions
Companies | Position | Start | End |
---|---|---|---|
American Society of Hypertension | Corporate Officer/Principal | 2009-08-26 | - |
Hibernaid, Inc.
![]() Hibernaid, Inc. BiotechnologyHealth Technology Hibernaid, Inc. develops and manufactures drugs. Its compound HBN-1 is used for resuscitated post-cardiac arrest patients as well as for the treatment of stroke, traumatic brain injury, spinal cord injury, and other acute critical care indications. The company was founded by Stephen J. Petti and Laurence M. Katz and is headquartered in Troy, NY. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - |
Career history of Stephen J. Petti
Former positions of Stephen J. Petti
Companies | Position | Start | End |
---|---|---|---|
Blue Note Pharmaceuticals BV
![]() Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Chief Executive Officer | - | 2014-02-03 |
Founder | 2009-08-26 | 2014-02-03 | |
President | - | 2014-02-03 | |
Vyv, Inc.
![]() Vyv, Inc. Electrical ProductsProducer Manufacturing VYV, Inc. designs, engineers, and manufactures germ-killing LED technology for an expanding range of commercial and residential applications. The company was founded by Colleen A. Costello and James Peterson and is headquartered in Troy, NY. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Barnett International
![]() Barnett International Miscellaneous Commercial ServicesCommercial Services Barnett International provides consulting services and conducts education training programs. It also provides services for companies in the pharmaceutical and biotechnology industries. The firm’s services include outsourcing management, clinical training, technological analysis and implementation. The company was founded in 1979 and is headquartered in Centreville, VA. | Corporate Officer/Principal | - | - |
DOV Pharmaceutical, Inc.
![]() DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - | - |
Empire Pharmaceuticals, Inc.
![]() Empire Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Neurobiological Technologies, Inc., Empire Pharmaceuticals, Inc. develops late-stage perfusion therapy for use in the treatment of acute ischemic stroke. The company is based in Newbury Park, CA. The company was founded by Stephen J. Petti, David E. Levy. Empire Pharmaceuticals was acquired by Neurobiological Technologies, Inc. on July 15, 2004 for $22.91 million. | Founder | - | - |
President | - | - | |
American Heart Association, Inc.
![]() American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 2009-08-26 | - |
NEUROBIOLOGICAL TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Training of Stephen J. Petti
St. John's University | Undergraduate Degree |
Dominican University New York | Undergraduate Degree |
Statistics
International
United States | 11 |
Netherlands | 2 |
Operational
Corporate Officer/Principal | 5 |
Chief Executive Officer | 3 |
Founder | 3 |
Sectoral
Commercial Services | 5 |
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
NEUROBIOLOGICAL TECHNOLOGIES, INC. | Health Technology |
Private companies | 8 |
---|---|
Blue Note Pharmaceuticals BV
![]() Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Health Technology |
American Heart Association, Inc.
![]() American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
American Society of Hypertension | |
Empire Pharmaceuticals, Inc.
![]() Empire Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Neurobiological Technologies, Inc., Empire Pharmaceuticals, Inc. develops late-stage perfusion therapy for use in the treatment of acute ischemic stroke. The company is based in Newbury Park, CA. The company was founded by Stephen J. Petti, David E. Levy. Empire Pharmaceuticals was acquired by Neurobiological Technologies, Inc. on July 15, 2004 for $22.91 million. | Commercial Services |
DOV Pharmaceutical, Inc.
![]() DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |
Barnett International
![]() Barnett International Miscellaneous Commercial ServicesCommercial Services Barnett International provides consulting services and conducts education training programs. It also provides services for companies in the pharmaceutical and biotechnology industries. The firm’s services include outsourcing management, clinical training, technological analysis and implementation. The company was founded in 1979 and is headquartered in Centreville, VA. | Commercial Services |
Vyv, Inc.
![]() Vyv, Inc. Electrical ProductsProducer Manufacturing VYV, Inc. designs, engineers, and manufactures germ-killing LED technology for an expanding range of commercial and residential applications. The company was founded by Colleen A. Costello and James Peterson and is headquartered in Troy, NY. | Producer Manufacturing |
Hibernaid, Inc.
![]() Hibernaid, Inc. BiotechnologyHealth Technology Hibernaid, Inc. develops and manufactures drugs. Its compound HBN-1 is used for resuscitated post-cardiac arrest patients as well as for the treatment of stroke, traumatic brain injury, spinal cord injury, and other acute critical care indications. The company was founded by Stephen J. Petti and Laurence M. Katz and is headquartered in Troy, NY. | Health Technology |
- Stock Market
- Insiders
- Stephen J. Petti
- Experience